Filing Details
- Accession Number:
- 0001178913-19-000509
- Form Type:
- 13G Filing
- Publication Date:
- 2019-02-14 11:32:15
- Filed By:
- Michael Ilan Management & Investment Ltd.
- Company:
- Quoin Pharmaceuticals Ltd.
- Filing Date:
- 2019-02-14
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Ilan Holdings (M I) Ltd | 14,489,100 | 0 | 14,489,100 | 0 | 14,489,100 | 11.1% |
| Arrow Pride (Eran Ilan ) | 14,489,100 | 0 | 14,489,100 | 0 | 14,489,100 | 11.1% |
Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND
(d) AND AMENDMENTS THEREOF FILED PURSUANT TO § 240.13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)*
(Amendment No. 2)*
Cellect Biotechnology Ltd.
(Name of Issuer)
American Depositary Shares, each representing twenty Ordinary Shares, no par value
(Title of Class of Securities)
15116C102
(CUSIP Number)
December 31, 2018
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ☐ | Rule 13d‑1(b) | |
| ☐ | Rule 13d‑1(c) | |
| ☒ | Rule 13d‑1(d) |
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 15116C102 | 13G/A | Page 2 of 6 Pages |
| 1. | Names of Reporting Persons | | | ||
| Ilan Holdings (M&I) Ltd. | | | |||
| | | ||||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (See Instructions) | | | ||
| (a) ☐ (b) ☐ | | ||||
| | | ||||
| 3. | SEC Use Only | | | ||
| | | | |||
| | | ||||
| 4. | Citizenship or Place of Organization | | | ||
| Israel | | | |||
| | | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | Sole Voting Power | | | |
| 14,489,100 (1) | | | |||
| | | ||||
| 6. | Shared Voting Power | | | ||
| 0 | | | |||
| | | ||||
| 7. | Sole Dispositive Power | | | ||
| 14,489,100 (1) | | | |||
| | | ||||
| 8. | Shared Dispositive Power | | | ||
| 0 | | | |||
| | | ||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person | | | ||
| 14,489,100 (1) | | | |||
| | | ||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) | | | ||
| ☐ | | | |||
| | | ||||
| 11. | Percent of Class Represented by Amount in Row (9) | | | ||
| 11.1% (2) | | | |||
| | | ||||
| 12. | Type of Reporting Person (See
Instructions) | | | ||
| IV | | | |||
| | | ||||
| (1) | Reflects sole voting/dispositive power as of January 29, 2019. Includes warrants ADS (Tradeable) to purchase 576,920 ordinary shares at an exercise price of NIS 1.4 per share and expiring on August 3, 2021. |
| (2) | Based upon 130,414,799 Ordinary
Shares issued and outstanding as of February 6, 2019 (as reported by the Issuer in its Form 424B4 filed with the Securities and Exchange Commission on February 11, 2019). |
| CUSIP No. 15116C102 | 13G/A | Page 3 of 6 Pages |
| 1. | Names of Reporting Persons | | | ||
| Arrow Pride (Eran Ilan) | | | |||
| | | ||||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (See Instructions) | | | ||
| (a) ☐ (b) ☐ | | ||||
| | | ||||
| 3. | SEC Use Only | | | ||
| | | | |||
| | | ||||
| 4. | Citizenship or Place of Organization | | | ||
| Israel, the United States of America and Canada | | | |||
| | | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | Sole Voting Power | | | |
| 14,489,100 (1) | | | |||
| | | ||||
| 6. | Shared Voting Power | | | ||
| 0 | | | |||
| | | ||||
| 7. | Sole Dispositive Power | | | ||
| 14,489,100 (1) | | | |||
| | | ||||
| 8. | Shared Dispositive Power | | | ||
| 0 | | | |||
| | | ||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person | | | ||
| 14,489,100 (1) | | | |||
| | | ||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) | | | ||
| ☐ | | | |||
| | | ||||
| 11. | Percent of Class Represented by Amount in Row (9) | | | ||
| 11.1% (2) | | | |||
| | | ||||
| 12. | Type of Reporting Person (See
Instructions) | | | ||
| IN | | | |||
| | | ||||
| (1) | Reflects sole voting/dispositive power as of January 29, 2019. Reflects sole voting/dispositive power as of January 29, 2019. Includes warrants ADS (Tradeable) to purchase 576,920 ordinary shares at an exercise price of NIS 1.4
per share and expiring on August 3, 2021. |
| (2) | Based upon 130,414,799 Ordinary
Shares issued and outstanding as of February 6, 2019 (as reported by the Issuer in its Form 424B4 filed with the Securities and Exchange Commission on February 11, 2019). |
| CUSIP No. 15116C102 | 13G/A | Page 4 of 6 Pages |
Item 1(a). Name of Issuer:
Cellect Biotechnology Ltd.
Item 1(b). Address of Issuer’s Principal Executive Offices:
23 Hata’as Street, Kfar Saba, Israel 44425.
Item 2(a). Name of Person Filing:
This Statement is filed by:
(1) Ilan Holdings (M&I)
Ltd.
(2) Arrow Pride (Eran Ilan)
The foregoing entities are collectively referred to as the "Reporting Persons" in this Statement.
Item 2(b). Address of Principal Offices or, if None, Residence:
Ilan Holdings (M&I)
Ltd. – Lev Hasharon Industrial Park, Kadima, P.O. Box 5062, Israel 6092000
Arrow Pride (Eran Ilan) –
c/o Ilan Holdings (M&I) Ltd., Lev Hasharon Industrial Park, Kadima, P.O. Box 5062, Israel 60920006
Item 2(c). Citizenship:
Place of organization of the Reporting Persons, as the case may be, is:
Ilan Holdings (M&I)
Ltd. – Israel
Arrow
Pride (Eran Ilan) – Israel, the United States of America and Canada
Item 2(d). Title of Class of Securities:
American Depositary Shares, each representing twenty Ordinary Shares Ordinary Shares, no par value (“Ordinary
Shares”).
Item 2(e). CUSIP Number:
15116C102
| Item 3. | If the Statement is being filed pursuant to Rule 13d‑1(b) or 13d‑2(b) or (c), check whether the filing person is a: |
Not applicable.
Item 4. Ownership.
(a) Amount beneficially owned:
14,489,100 Ordinary Shares.
(b) Percent of class:
11.1%
(c) Number of shares as to which
such person has:
(i) Sole
power to vote or direct the vote: 14,489,100
(ii) Shared
power to vote or direct the vote: 0
| CUSIP No. 15116C102 | 13G/A | Page 5 of 6 Pages |
(iii) Sole
power to dispose or to direct the disposition of: 14,489,100
(iv) Shared
power to dispose or to direct the disposition of: 0
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person had ceased to be the
beneficial owner of more than 5 percent of the class of securities, check the following ☐.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
Not applicable.
| CUSIP No. 15116C102 | 13G/A | Page 6 of 6 Pages |
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this
statement is true, complete and correct.
February 14, 2019
| | Ilan Holdings (M&I) Ltd. By: /s/ Arrow Pride (Eran Ilan) Name: Arrow Pride (Eran Ilan) Title: Director Arrow Pride (Eran Ilan) /s/ Arrow Pride
(Eran Ilan) |